Marrone Bio Innovations

Marrone Bio Innovations, Inc., a biopesticide company, engages in the discovery, development, and marketing of natural products for weed, pest, and plant disease management. Its products include Regalia, a product that protects food and ornamental crops from fungal and bacterial diseases; GreenMatch EX, a post-emergence herbicide for burndown weed control for organic growers; and GreenMatch, a burndown herbicide that controls various annual and perennial weeds. The company also offers insecticides, herbicides, and products for controlling invasive zebra and quagga mussels in waterways. In addition, it finds naturally occurring microorganisms from habitats and develops them into products for controlling insects, weeds, nematodes, and plant diseases. The company provides its products online. Marrone Bio Innovations, Inc. was founded in 2006 and is based in Davis, California.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Pro Farm Group, Inc. engages in the provision of biological-based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. Its products include Grandevo Insecticide, Majestene Nematicide, Regalia Fungicide, Stargus Fungicide, Venerate Insecticide, Amplitude Fungicide, Regalia Rx Plant Health, Zelto Nematicide, Zequanox Molluscicide and Haven. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Raleigh, NC.

MBI Biopesticides Likely Reduce Greenhouse Gas Emissions 69% to 91% as Compared with Conventional Chemical Pesticide Products MBI Biopesticides Likely Reduce Greenhouse Gas Emissions 69% to 91% as Compared with Conventional Chemical Pesticide Products

Marrone Bio Announces New Study Comparing Greenhouse Gas Impact of its Products Compared with Conventional Chemical Products

Arena Pharmaceuticals

Cara Therapeutics

Corbus Pharmaceuticals Holdings

Cronos Group

Greenlane Holdings

GW Pharmaceuticals

New Age Beverages

Intec Parent

OrganiGram Holdings Inc.

Psychemedics

SNDL Inc.

Tilray Brands

Therapix Biosciences

Village Farms International

Zynerba Pharmaceuticals

The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges.

Top Marijuana Stocks on the NASDAQ

Novel biofungicide effective on specialty crops for yield-robbing diseases

Marrone Bio Announces Approval of Stargus® Biofungicide in California

New Credit Facilities to Address Working Capital Required to Support Growing Sales New Credit Facilities to Address Working Capital Required to Support Growing Sales

Marrone Bio Innovations Announces New $23 Million Accounts-Receivable and Inventory-Backed Credit Facilities

DAVIS, Calif., Jan.  07, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that two of its biofungicide products—Stargus® and Regalia®—have been approved by the United States Environmental Protection Agency (EPA) for indoor and outdoor use on hemp plants.

Marrone Bio Innovations Announces U.S. EPA Approval of Regalia® and Stargus® for Hemp

Field Trials Support Potential New Treatment Option for Corn Growers Field Trials Support Potential New Treatment Option for Corn Growers

Marrone Bio’s Next-Generation Nematicide/Insecticide Demonstrates Improved Levels of Crop Protection and Yield

Trials Conducted Internationally by Marrone Bio and its Wholly Owned Subsidiary, Pro Farm Technologies OY Trials Conducted Internationally by Marrone Bio and its Wholly Owned Subsidiary, Pro Farm Technologies OY

Marrone Bio Seed Treatments Demonstrate Improved Yields and Cost-Effective Control

Founder and CEO Pamela Marrone to Retire from the Company; Search Process for New CEO Under Way Founder and CEO Pamela Marrone to Retire from the Company; Search Process for New CEO Under Way

Marrone Bio Innovations Announces Plans for CEO Succession

Marrone Bio Innovations, Inc. (MBII) CEO Pam Marrone on Q3 2019 Results - Earnings Call Transcript

U.S. Patent Claims Cover Pre- and Post-Emergent Herbicidal Activity to Control Weeds U.S. Patent Claims Cover Pre- and Post-Emergent Herbicidal Activity to Control Weeds

New Field Trials for Marrone Bio’s Novel Bioherbicide Show Effective Control of Palmer Amaranth Weed

DAVIS, Calif., Oct.  01, 2019  (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that its novel Bacillus Biofungicide, marketed in the U.S. as Stargus® for specialty crops, was approved for use in Mexico by the Ministry of Health COFEPRIS.  Stargus will be used in Mexico to control downy mildews, late blight and a broad range of other plant related diseases on zucchini, squash, chayote, melon, cucumber, watermelon and potato crops.

Marrone Bio Innovations Announces Approval of Stargus® in Mexico

New Subsidiary Enters into Strategic, Long-Term Exclusive Commercial Agreement in Europe with Corteva Agriscience New Subsidiary Enters into Strategic, Long-Term Exclusive Commercial Agreement in Europe with Corteva Agriscience

Marrone Bio Announces Closing of Pro Farm Technologies Acquisition

New product lines provide immediate revenue growth and near-term earnings accretion New product lines provide immediate revenue growth and near-term earnings accretion

Marrone Bio Acquires Jet Ag and Jet Oxide Product Lines;  Significantly Expands Opportunity in Agricultural Bioprotection Market

DAVIS, Calif., Aug.  28, 2019  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII), a leading developer of bio-based products for pest management and plant health, today announced that management will attend several investor conferences in San Francisco and New York throughout September 2019.

Marrone Bio Innovations to Present at Upcoming Investor Conferences

DAVIS, Calif., Aug.  28, 2019  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced that Dr. Pam Marrone, Founder and Chief Executive Officer, has received the 2019 American Chemical Society (ACS)  Award for Innovation in Chemistry of Agriculture , sponsored by the Agrochemical Division of ACS and BASF Corporation, in honor of outstanding achievements in the discovery, development and commercialization of biopesticides.

Marrone Bio Innovations CEO Dr. Pam Marrone Receives Innovation Award in Chemistry of Agriculture from the American Chemical Society

Marrone Bio Innovations' (MBII) CEO Pam Marrone on Q2 2019 Results - Earnings Call Transcript

Marrone Bio Innovations, Inc. (MBII) CEO Pamela Marrone on Q1 2019 Results - Earnings Call Transcript

Crop protection and plant health solutions company Marrone Bio Innovations Inc reported financial results for the fourth quarter and full year Thursday.

Marrone Bio Reports Q4 Earnings, Plans To Prioritize Cannabis Market

Marrone Bio Innovations, Inc. (MBII) CEO Pam Marrone on Q4 2018 Results - Earnings Call Transcript

News for Marrone Bio Innovations Stock (MBII)